3 glp 1 drugs GLP-1 weight loss may be misused by patients with eating disorders: Study New GLP-1 Guidelines for Type
Description
Importantly, liraglutide also normalized high-fat diet (HFD) intake during withdrawal, a commonly observed phenotype in nicotine-abstinent individuals and a major contributor to smoking relapse in humans
doi: 10.3390/ijms20215407
However, evidence regarding the association between GLP-1RAs and liver cancer risk is currently limited
doi: 10.1210/en.2006-0153 [DOI] [PubMed] [Google Scholar] 164
Like GLP-1, GIP also stimulates insulin secretion ( Click here to read more about this)
On April 1, the FDA approved Foundayo (orforglipron), Eli Lillys once-daily oral GLP-1 receptor agonist for obesity, which is the first oral GLP-1 approved for weight management and the fastest new molecular entity approval since 2002
